
Sign up to save your podcasts
Or


On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By POLITICO4.7
453453 ratings
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices

610 Listeners

1,517 Listeners

692 Listeners

112,617 Listeners

964 Listeners

308 Listeners

56,472 Listeners

106 Listeners

500 Listeners

206 Listeners

674 Listeners

6,445 Listeners

140 Listeners

387 Listeners

41 Listeners

12 Listeners

606 Listeners